BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33728448)

  • 1. A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.
    Tian XP; Ma SY; Young KH; Ong CK; Liu YH; Li ZH; Zhai QL; Huang HQ; Lin TY; Li ZM; Xia ZJ; Zhong LY; Rao HL; Li M; Cai J; Zhang YC; Zhang F; Su N; Li PF; Zhu F; Xu-Monette ZY; Wong EKY; Ha JCH; Khoo LP; Ai L; Cheng RF; Lim JQ; de Mel S; Ng SB; Lim ST; Cai QQ
    Blood; 2021 Aug; 138(6):452-463. PubMed ID: 33728448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
    Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
    Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.
    Huang Y; Jia B; Jiang S; Zhou S; Yang J; Liu P; Gui L; He X; Qin Y; Sun Y; Shi Y
    J Hematol Oncol; 2017 Jan; 10(1):7. PubMed ID: 28057019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic evaluation of the prognostic value of
    Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W
    Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
    Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Nomogram for Overall Survival in Early Stage Extranodal Natural Killer/T Cell Lymphoma Treated With High-Dose Radiotherapy.
    Huang L; Wu Y; Wang Y; Xie Y; Wu F; Li S; Liang Z; Zhu X
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):289-295. PubMed ID: 32122775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an
    Wang H; Zhao S; Li L; Tian R
    Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients.
    Li K; Wang R; Huang S; Pan X; Chen H; Zhou L; Wei J; Wu C; Zhu X; Liang S; Qu S
    Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e537-e543. PubMed ID: 30243570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
    Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL
    EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Prediction of Survival for Sinonasal Extranodal Natural Killer/T-cell Lymphoma.
    Wang T; Qiu Y; Shi L; Chen D; Chen X; Liu J; Liu T
    Laryngoscope; 2023 Jul; 133(7):1645-1651. PubMed ID: 37294046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma.
    Mao J; Yin H; Wang L; Wu JZ; Xia Y; Zhu HY; Fan L; Li JY; Liang JH; Xu W
    Ann Hematol; 2021 Feb; 100(2):445-453. PubMed ID: 33140135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
    Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
    Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I
    Wang HY; Niu SQ; Yang YY; Li YY; Chen HB; Zhang YJ
    Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma.
    Wang L; Chi PD; Chen H; Xiang J; Xia ZJ; Zhang YJ
    Tumour Biol; 2014 Mar; 35(3):2141-9. PubMed ID: 24122233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.
    Liu X; Liang Y; Shen Z; Wei L; Yang J; Piao Y; Sang W; Li P; Wang L
    Cancer Med; 2023 May; 12(9):10660-10671. PubMed ID: 36924334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.